Groups push FDA to revoke approval of highly potent painkiller

The Philadelphia Inquirer / HealthDay News, February 27, 2014
Dozens of experts and health care agencies sent a letter this week urging that the U.S. Food and Drug Administration revoke its approval of the supercharged painkiller, Zohydro. In the petition sent to the FDA on Wednesday, more than 40 consumer watchdog groups, addiction treatment groups and others noted that the drug was approved despite significant resistance from the FDA's own advisory committee, which voted 11-2 against allowing Zohydro to be sold. According to consumer advocate group Public Citizen, which issued its own news release on the issue Wednesday, a single dose of Zohydro could kill a child.

MOST POPULAR

" style="font-family:inherit">Physician's Scathing Remarks Humiliate Patient, Cost Hospital
  • Alternative Staffing Arrangements
  • " style="font-family:inherit">The Perils of Cut-and-Paste Documentation
  • Aging Doctors: Time for Mandatory Competency Testing?
  • 7 Years In, Triple Aim Transcends Jargon
  • Alternative Staffing Arrangements
  • CMS Predictive Readmission Models 'Not Very Good'
  • SPONSORED REPORTS
    SPONSORED HEADLINES

    SIGN UP

    FREE e-Newsletters Join the Council Subscribe to HL magazine

    SPONSORSHIP & ADVERTISING

    100 Winners Circle Suite 300
    Brentwood, TN 37027

    800-727-5257

    About | Advertise | Terms of Use | Privacy Policy | Reprints/Permissions | Contact
    © HealthLeaders Media 2014 a division of BLR All rights reserved.